We are driving the future of America’s biopharma innovation. Our $32 billion commitment to U.S. manufacturing is an investment in the next generation of scientists, communities and R&D. Read more on The Hill: https://gilead.inc/4iep4Ac. #CreatingPossibleInAmerica #AmericanInnovation
About us
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Foster City, CA
- Type
- Public Company
Locations
Employees at Gilead Sciences
-
john milam
-
Brad Margolis, Ph.D.
Talent Management & Development | Accelerating Strategic Growth | Leadership, Organization & Team Effectiveness | Breakthrough Performance
-
Michele Chase Kashap, MBA
Global Biotechnology Commercial Leader
-
Susan Jameson
Administrative Coordinator at Gilead Sciences
Updates
-
We left #ABCLisbon last week with critical perspectives from advocates and healthcare providers on the importance of treatment innovation for more aggressive cancers, like metastatic triple-negative breast cancer. Hear what drives hope and progress for the #MBC community. #ABC8
-
What does it take to turn invisible symptoms into visible art? Mondo Guerra shares creative outfits inspired by real people living with PBC.
All The Feelings With PBC
-
#GileadNews: We’ve announced positive topline results from a Phase 3 HIV research trial evaluating an investigational novel treatment combination with the potential to expand options. Read more: https://gilead.inc/43vLiaB
-
At Gilead, advancing cutting-edge research and supporting emerging scientific talent is core to our mission. Since 2008, our Research Scholars Program has helped to close knowledge gaps and address unmet needs in Virology, Liver Disease and Oncology. Building on the success of these initiatives, we have now extended our support to independent research exclusively in primary biliary cholangitis (PBC). During The Liver Meeting® in Washington D.C., we were proud to welcome four outstanding new awardees to our program, each selected for their innovative research and potential to drive meaningful impact in PBC. 🎉 Victoria Mulcahy, MD, PhD (UK) 🎉 Russell Rosenblatt, MD, MS (NY, USA) 🎉 Tianliang Sun, PhD (NY, USA) 🎉 Vincenzo Ronca, MD, PhD (Italy) We’re continuing to build a global community of thought leaders driving progress in liver disease. Together, we’re shaping a healthier future. Learn more about the program here: https://gilead.inc/3Xs9xTy #LiverDisease #PBC #GileadSciences #ResearchScholars #TLM2025 #FutureOfMedicine
-
-
From the meticulous lab work of research scientists to the strategic coordination of logistics, every step of the way our manufacturing team plays a crucial role in bringing our transformative medicines to patients. In celebration of October’s Manufacturing Month, we’re “passing the phone” spotlighting these employees to show how their different roles unite to provide a meaningful impact to help ensure access to treatment. Come along with us on this Day in the Life journey and go behind the scenes of Gilead. #GileadLife
-
As both Associate General Counsel and a veteran, Mark Hurvitz brings leadership, discipline and purpose to Kite Pharma’s manufacturing and quality teams. Hear how he applies lessons from his military service to advance innovation at Kite. #VeteransDay
-
At Gilead, we believe that ending #HIV is only possible when we work together. That’s why we hosted an HIV Prevention Advocacy Summit alongside community advocates, healthcare leaders, and experts. By coming together, we can share knowledge, spark new ideas and identify real solutions that make prevention accessible for all, especially those in the communities most impacted. Together, we can help end HIV. #HIVPreventionAdvocacySummit
-
-
#GileadNews: At #TLM, we’re presenting new interim, long-term data in primary biliary cholangitis (PBC). Learn about our ongoing commitment to addressing the unmet needs of people living with PBC: https://gilead.inc/3LNj05i
-
Listen as advocates share why they dedicate their lives to speaking up for others living with cancer. Advocacy is especially critical for people living with metastatic #breastcancer, who often face significant unmet needs.
Transforming Cancer Treatment